Thanks to the participation of a panel of nationally and internationally renowned speaker the meeting aims to:
- Expanding participants’ knowledge about clinical indications and advantages of hadrontherapy in an international overview and perspectives
- Informing participants on managerial, technical and clinical aspect of an hadrontherapy facility
- Improving understanding on resource requirements, challenges, economical and social implications of hadrontherapy
- Presenting status and perspectives of a new research clinical modality, BNCT (Boron Neutron Capture Therapy)
09:00 Participant Registration 09:30 Welcome Addresses
SESSION 1: CLINICAL ACTIVITIES
Moderatore: Lisa Francesca Linda Licitra 09:45 Keynote lecture Historical and scientific evolution of hadrontherapy Ugo Amaldi 10:15 Hadrontherapy in the context of cancer care in Italy Marco Krengli 10:35 Hadrontherapy vs X-ray therapy: clinical aspects, patient pathway and clinical QA considerations
Ester Orlandi 10:55 Chordoma and Chondrosarcoma Piero Fossati 11:15 Coffee Break 11:30 Head and Neck cancers Barbara Vischioni 11:50 Central Nervous System tumors Semi Harrabi 12:10 Gastroenteric and gynaecological tumors Amelia Barcellini 12:30 Pediatric cancers Sabina Vennarini 12:50 Heavy ions for prostate cancer: how to manage pelvic nodes? Mack Roach 13:10 Lunch SESSION 2: CLINICAL ACTIVITIES Moderatore: Mario Ciocca 14:30 Clinical research and future prospective Roberto Orecchia 14:50 Clinical dosimetry and quality assurance Markus Stock 15:10 Patient clinical workflow including image guidance Guido Baroni 15:30 Treatment planning: comparing techniques and standards Silvia Molinelli 15:50 Coffee Break 16:05 Radiobiology: current trend and future prospective Micheal Story 16:25 Novel approaches in particle therapy Andrea Mairani 16:45 Implementing a carbon ion facility: the Mayo Clinic Project Laura Vallow 19:30 Social Event SESSION 3: HEALTH POLICY CONTEXT AND HEALTH ECONOMICS OF HADRON THERAPY Moderatore: Andrea Riccardo Filippi 09:00 ENLIGHT (European Network for Light Ion Hadron Therapy) and its role in Hadron Therapy Manjit Dosanjh 09:20 Academia meets Industry: IP, communication, managing expectations Manuela Cirilli 09:40 Funding and health economic Fabio Michele Amatucci 10:00 Financial toxicity: PSI experience Barbara Bachtiary 10:20 CNAO: cost benefit Analysis Maria Vittoria Livraga 10:40 Coffee Break SESSION 4: ORGANIZATION AND OPERATION OF MULTI PARTICLE THERAPY FACILITY Moderatore: Marco Cianchetti 11:00 The Heidelberg Ion Beam Therapy Center - Technology, Clinical Application and Research Thomas Haberer 11:20 The CNAO facility: operation and maintenance Giuseppe Venchi 11:40 The MedAustron facility Christoph Kurfuerst 12:00 The Marburg facility Klemens Zink 12:20 New accelerator designs: NIMMS Maurizio Vretenar 12:40 The vision of the SEEIIST project Leander Litov 13:00 Carbon facilities outside Europe with focus on USA/NCI programme Arnold Pompos 13:20 Lunch SESSION 5: RESEARCH & DEVELOPMENT IN HADRONTHERAPY Moderatore: Giuseppe Antonio Pablo Cirrone 14:30 Building capacity through the IAEA programs Sotirios Charisopoulos 14:50 HITRIplus project overview Angelica Facoetti 15:10 Imaging: current trends and future perspectives Katia Parodi 15:30 Flash Therapy with light ions Emanuele Scifoni 15:50 Coffee Break 16:05 Upright positioning and arc therapy Christian Graeff 16:25 New Gantry for ions Marco Giuseppe Pullia 16:45 New technologies: superconducting magnets Lucio Rossi 17:05 Discussion 17:30 Visit of CNAO BNCT: SESSION 1
Chair: Saverio Altieri – Paolo Pedrazzoli
09:00 Hadron therapy in radiation oncology and why BNCT is a paradigm shift Wolfgang Sauerwein 09:20 Clinical BNCT experience with accelerators Minoru Suzuki 09:40 BNCT clinical trials Peeter Karihtala 10:00 Progress to clinical adoption of accelerator based BNCT Lisa Licitra 10:20 Development of new novel BNCT drugs Kendall Morrison 10:40 Online boron dose distribution imaging Nicoletta Protti 11:00 Coffee break BNCT: SESSION 2
Chair: Valerio Vercesi – Barbara Croesi
11:20 Radiobiological characterization of a BNCT beam Mitsuko Masutani 11:40 Dosimetry in BNCT Stuart Green 12:00 Micro-dosimetry of a neutron BNCT beam Valeria Conte 12:20 Treatment planning for BNCT Ian Postuma 12:40 Discussion 13:00 Lunch BNCT: SESSION 3
Chair: Stefano Agosteo – Laura Locati
14:00 Structural basis of cancer cells uptake of boronated compounds Vittorio Bellotti 14:20 Accelerator based neutron sources for BNCT Andres Kreiner 14:40 Development of the IAEA publication ‘Advances in Boron Neutron Capture Therapy Ian Swainson 15:00 BNCT@CNAO Sandro Rossi 15:20 Discussion and closing remarks 15:40 Visit of LENA
This course is reserved to a limited number of participants.
Participation in this course is free of charge.
Completing the online registration is mandatory to attend this course.
To obtain CME credits, users must meet the following requirements:
- Their declared profession/specialization must correspond to those accredited for CME.
- They must attend at 100% of the course (watching the recorded event is not enough).
- They must complete the online meeting evaluation form.
- They must pass the learning assessment test with at least 75% correct answers. Five attempts are allowed.
The learning assessment test and meeting evaluation form must be submitted within three days of the event.
Please note that in order to access the learning assessment test, users must (A) attend at least 75% of each session constituting the course and (B) submit the online meeting evaluation form.
Certificate of attendance
To download the certificate of attendance, users must (A) have attended at least 75% of each session constituting the course and (B) have submitted the online meeting evaluation form.
Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere